BrainStorm Cell Therapeutics Inc., a leading developer of cellular therapies for neurodegenerative diseases, and Catalent (NYSE: CTLT), a global leader in enabling biopharma, cell, gene and consumer health partners to optimize development, launch, and supply of better...
Food industry, government and contract testing laboratories performing food safety analysis can now benefit from a new portfolio that offers cost-effective, robust Solid-Phase Extraction (SPE) solutions to support food safety workflows and meet regulatory requirements...
Pfizer Inc. and BioNTech SE today announced that the U.S. Food and Drug Administration (FDA) has expanded the Emergency Use Authorization (EUA) of a booster dose of the Pfizer-BioNTech COVID-19 Vaccine to include individuals 16 years of age and older. The booster dose...
Exact Sciences today announced the company is committing $500,000 to support construction of the Urban League of Greater Madison’s Black Business Hub (The Hub) on the city’s south side. Exact Sciences also plans to lease space in the building to connect with...
Merck, known as MSD outside the United States and Canada, announced today an additional $150 million commitment through Merck for Mothers to further advance the initiative’s mission of helping create a world where no woman has to die giving life. This investment...